<DOC>
	<DOC>NCT01213160</DOC>
	<brief_summary>The primary purpose of this study is to explore the safety and tolerability of AZD4547 in Japanese patients with advanced solid malignancies.</brief_summary>
	<brief_title>Study to Assess Safety and Tolerability of AZD4547 in Japanese Patient</brief_title>
	<detailed_description>A Phase I, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumour Activity of Ascending Doses of AZD4547 in Japanese Patients with Advanced Solid Malignancies.</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Japanese patients with advanced solid malignancies Over 25 years old Relatively good overall health other than cancer Poor bone marrow function (not producing enough blood cells). Poor liver or kidney function. Refractory nausea and vomiting, chronic gastrointestinal diseases, inability to swallow the IP or previous significant bowel resection.</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>150 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Phase I</keyword>
	<keyword>cancer</keyword>
	<keyword>solid tumours</keyword>
	<keyword>advanced solid malignancies</keyword>
	<keyword>dose escalation</keyword>
	<keyword>FGFR TKI</keyword>
	<keyword>Japanese</keyword>
</DOC>